全文获取类型
收费全文 | 23216篇 |
免费 | 1243篇 |
国内免费 | 205篇 |
专业分类
耳鼻咽喉 | 329篇 |
儿科学 | 513篇 |
妇产科学 | 246篇 |
基础医学 | 3024篇 |
口腔科学 | 347篇 |
临床医学 | 1398篇 |
内科学 | 6620篇 |
皮肤病学 | 558篇 |
神经病学 | 1669篇 |
特种医学 | 976篇 |
外科学 | 3811篇 |
综合类 | 81篇 |
预防医学 | 540篇 |
眼科学 | 452篇 |
药学 | 1273篇 |
中国医学 | 42篇 |
肿瘤学 | 2785篇 |
出版年
2023年 | 148篇 |
2022年 | 292篇 |
2021年 | 636篇 |
2020年 | 315篇 |
2019年 | 413篇 |
2018年 | 625篇 |
2017年 | 483篇 |
2016年 | 540篇 |
2015年 | 587篇 |
2014年 | 716篇 |
2013年 | 892篇 |
2012年 | 1394篇 |
2011年 | 1617篇 |
2010年 | 972篇 |
2009年 | 845篇 |
2008年 | 1428篇 |
2007年 | 1502篇 |
2006年 | 1516篇 |
2005年 | 1519篇 |
2004年 | 1530篇 |
2003年 | 1381篇 |
2002年 | 1370篇 |
2001年 | 298篇 |
2000年 | 235篇 |
1999年 | 300篇 |
1998年 | 301篇 |
1997年 | 247篇 |
1996年 | 186篇 |
1995年 | 197篇 |
1994年 | 170篇 |
1993年 | 151篇 |
1992年 | 159篇 |
1991年 | 166篇 |
1990年 | 119篇 |
1989年 | 130篇 |
1988年 | 101篇 |
1987年 | 97篇 |
1986年 | 91篇 |
1985年 | 101篇 |
1984年 | 89篇 |
1983年 | 71篇 |
1982年 | 57篇 |
1981年 | 66篇 |
1980年 | 56篇 |
1979年 | 54篇 |
1978年 | 48篇 |
1977年 | 43篇 |
1972年 | 39篇 |
1970年 | 46篇 |
1969年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
992.
993.
Manabu Fujimoto Jun Asai Yoshihide Asano Takayuki Ishii Yohei Iwata Tamihiro Kawakami Masanari Kodera Masatoshi Abe Masahiro Amano Ryuta Ikegami Taiki Isei Zenzo Isogai Takaaki Ito Yuji Inoue Ryokichi Irisawa Masaki Ohtsuka Yoichi Omoto Hiroshi Kato Takafumi Kadono Sakae Kaneko Hiroyuki Kanoh Masakazu Kawaguchi Ryuichi Kukino Takeshi Kono Monji Koga Keisuke Sakai Eiichi Sakurai Yasuko Sarayama Yoichi Shintani Miki Tanioka Hideaki Tanizaki Jun Tsujita Naotaka Doi Takeshi Nakanishi Akira Hashimoto Minoru Hasegawa Masahiro Hayashi Kuninori Hirosaki Hideki Fujita Hiroshi Fujiwara Takeo Maekawa Koma Matsuo Naoki Madokoro Sei-Ichiro Motegi Hiroshi Yatsushiro Osamu Yamasaki Yuichiro Yoshino Andres James LE Pavoux Takao Tachibana Hironobu Ihn Japanese Dermatological Association Guidelines 《The Journal of dermatology》2020,47(10):1071-1109
The Japanese Dermatological Association prepared guidelines focused on the treatment of skin ulcers associated with connective tissue disease/vasculitis practical in clinical settings of dermatological care. Skin ulcers associated with connective tissue diseases or vasculitis occur on the background of a wide variety of diseases including, typically, systemic sclerosis but also systemic lupus erythematosus (SLE), dermatomyositis, rheumatoid arthritis (RA), various vasculitides and antiphospholipid antibody syndrome (APS). Therefore, in preparing the present guidelines, we considered diagnostic/therapeutic approaches appropriate for each of these disorders to be necessary and developed algorithms and clinical questions for systemic sclerosis, SLE, dermatomyositis, RA, vasculitis and APS. 相似文献
994.
Daisuke Ishibashi Takeshi Ishikawa Satoshi Mizuta Hiroya Tange Takehiro Nakagaki Tsuyoshi Hamada Noriyuki Nishida 《Neurotherapeutics》2020,17(4):1836
The accumulation of abnormal prion protein (PrPSc) produced by the structure conversion of PrP (PrPC) in the brain induces prion disease. Although the conversion process of the protein is still not fully elucidated, it has been known that the intramolecular chemical bridging in the most fragile pocket of PrP, known as the “hot spot,” stabilizes the structure of PrPC and inhibits the conversion process. Using our original structure-based drug discovery algorithm, we identified the low molecular weight compounds that predicted binding to the hot spot. NPR-130 and NPR-162 strongly bound to recombinant PrP in vitro, and fragment molecular orbital (FMO) analysis indicated that the high affinity of those candidates to the PrP is largely dependent on nonpolar interactions, such as van der Waals interactions. Those NPRs showed not only significant reduction of the PrPSc levels but also remarkable decrease of the number of aggresomes in persistently prion-infected cells. Intriguingly, treatment with those candidate compounds significantly prolonged the survival period of prion-infected mice and suppressed prion disease-specific pathological damage, such as vacuole degeneration, PrPSc accumulation, microgliosis, and astrogliosis in the brain, suggesting their possible clinical use. Our results indicate that in silico drug discovery using NUDE/DEGIMA may be widely useful to identify candidate compounds that effectively stabilize the protein.Electronic supplementary materialThe online version of this article (10.1007/s13311-020-00903-9) contains supplementary material, which is available to authorized users. 相似文献
995.
996.
997.
Inge A. Mulder MSc Mei Li PhD Tessa de Vries MSc Tao Qin Takeshi Yanagisawa MD PhD Kazutaka Sugimoto MD PhD Antoon van den Bogaerdt PhD A. H. Jan Danser MD PhD Marieke J. H. Wermer MD PhD Arn M. J. M. van den Maagdenberg PhD Antoinette MaassenVanDenBrink PhD Michel D. Ferrari MD PhD Cenk Ayata MD PhD 《Annals of neurology》2020,88(4):771-784
998.
Eriko Yanagida Hiroaki Miyoshi Mai Takeuchi Noriaki Yoshida Kazutaka Nakashima Kyohei Yamada Takeshi Umeno Yasumasa Shimasaki Takuya Furuta Masao Seto Koichi Ohshima 《Hematological oncology》2020,38(5):680-688
The interaction of CD47 and signal-regulatory protein alpha (SIRPα) induces “don't eat me signal”, leading suppression of phagocytosis. This signal can affect the clinical course of malignant disease. Although CD47 and SIRPα expression are associated with clinicopathological features in several neoplasms, the investigation for adult T-cell leukemia/lymphoma (ATLL) has not been well-documented. This study aimed to declare the association between CD47 and SIRPα expression and clinicopathological features in ATLL. We performed immunostaining on 73 biopsy samples and found that CD47 is primarily expressed in tumor cells, while SIRPα is expressed in non-neoplastic stromal cells. CD47 positive cases showed significantly higher FoxP3 (P = .0232) and lower CCR4 (P = .0214). SIRPα positive cases presented significantly better overall survival than SIRPα negative cases (P = .0132). SIRPα positive cases showed significantly HLA class I (P = .0062), HLA class II (P = .0133), microenvironment PD-L1 (miPD-L1) (P = .0032), and FoxP3 (P = .0229) positivity. In univariate analysis, SIRPα expression was significantly related to prognosis (Hazard ratio [HR] 0.470; 95% confidence interval [CI] 0.253-0.870; P = .0167], although multivariate analysis did not show SIPRα as an independent prognostic factor. The expression of SIRPα on stromal cells reflects activated immune surveillance mechanism in tumor microenvironment and induce good prognosis in ATLL. More detailed studies for gene expression or genomic abnormalities will disclose clinical and biological significance of the CD47 and SIRPα in ATLL. 相似文献
999.
Ota Yumiko Takahari Daisuke Suzuki Takeshi Osumi Hiroki Nakayama Izuma Oki Akira Wakatsuki Takeru Ichimura Takashi Ogura Mariko Shinozaki Eiji Suenaga Mitsukuni Chin Keisho Yamaguchi Kensei 《Cancer chemotherapy and pharmacology》2020,85(2):265-272
Cancer Chemotherapy and Pharmacology - In the ATTRACTION-2 trial, nivolumab significantly improved the survival of advanced gastric cancer patients. The pretreatment neutrophil-to-lymphocyte ratio... 相似文献
1000.
Tetsuji Terazawa Jin Matsuyama Masahiro Goto Ryohei Kawabata Shunji Endo Motohiro Imano Shoichiro Fujita Yusuke Akamaru Hirokazu Taniguchi Mitsutoshi Tatsumi Sang-Woong Lee Yoshitaka Kurisu Hisato Kawakami Yukinori Kurokawa Toshio Shimokawa Daisuke Sakai Takeshi Kato Kazumasa Fujitani Taroh Satoh 《The oncologist》2020,25(2):119-e208